X
At long last, Amgen/UCB score FDA okay for Evenity
https://pharmaphorum.com/news/at-long-last-amgen-ucb-score-fda-okay-for-evenity/
UCB
FDA approves UCB’s Cimzia in plaque psoriasis
The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis
